Ophthalmic Adaptive Optics (AO) Retinal Imaging System
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
About this archived opportunity
The Food and Drug Administration (FDA), Center for Devices and Radiological Health (CDRH), Office of Science and Engineering Laboratories (OSEL), Division of Biomedical Physics (DBP) intends to acquire one (1) Ophthalmic Adaptive Optics (AO) Retinal Imaging System. The system will be used to support retinal imaging research, biomarker development, and regulatory science activities at the FDA White Oak Campus in Silver Spring, Maryland. Delivery and installation shall be made to 10903 New Hampshire Avenue, Building WO62, Room G101, Silver Spring, MD 20993. For complete requirements, terms, and conditions, please refer to the attached Combined Synopsis/Solicitation (CSS) document No. RFQ-FDA-133666 .
Historical details
- Status
- Closed
- Deadline
- June 16, 2026
- First captured
- June 8, 2026
- Publisher reference
- bb0ad22260c44b928c01adfe832e942c
Eligibility: Total Small Business Set-Aside (FAR 19.5). SBA
This opportunity has closed
Ophthalmic Adaptive Optics (AO) Retinal Imaging System
by HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Get notified when similar opportunities open
We'll save this search and email you when new ophthalmic, adaptive, optics opportunities are posted. Free.
Related opportunities
- 6540--NX EQ Scanning Systems Ultrasonic Ophthalmic AB Scan (VA-27-00003110)VETERANS AFFAIRS, DEPARTMENT OF
- Notice of Intent to Award a Sole Source Commercial Simplified Acquisition Procedures (SAP) Contract for Development of a Human Neural Network Formation New Approach Method for the Evaluation of Potential Developmental NeurotoxicityHEALTH AND HUMAN SERVICES, DEPARTMENT OF
- 3D Medical Applications Center - Notice of Intent to Sole SourceDEPT OF DEFENSECloses in 64 days
- LSM990 Confocal Airscan2 SystemHEALTH AND HUMAN SERVICES, DEPARTMENT OF